Raising the Standard: New Pediatric Guidelines for Neuromuscular Block Management
Recording from live webinar Nov 13, 2025
Expert discussion to review the new ESAIC/ESPA recommendations, the anticipated global impact, and the practical strategies for integrating these guidelines into everyday clinical practice.
Key highlights in this webinar
The webinar, moderated by Jen Sanders, featured Dr. Joseph Tobias and Dr. Arash Afshari discussing new pediatric guidelines for neuromuscular block management.
- Dr. Tobias highlighted the importance of monitoring neuromuscular blockade, noting that sugamadex is effective but can cause recurarization in small infants. He emphasized the need for quantitative monitoring to prevent residual blockade.
- Dr. Afshari presented the European guidelines, recommending neuromuscular blockade for tracheal intubation and selective use in surgery. He stressed the importance of quantitative monitoring and sugamadex over neostigmine for reversal.
- Both speakers underscored the need for better monitoring practices and guidelines to improve patient outcomes.
About the presenters
- Arash Afshari, M.D., Ph.D.
Head of Research, Associate Professor, Department of Pediatric and Obstetric Anesthesia, Juliane Marie Centre, Rigshospitalet
Department of Clinical Medicine, Copenhagen University, Denmark
Past Chair of European Society of Anesthesiology and Intensive Care (ESAIC) Guideline Committee & Senior Methodologist at ESAIC
- Joseph D. Tobias, MD
Chief, Department of Anesthesiology & Pain Medicine
Nationwide Children's Hospital
Professor of Anesthesiology & Pediatrics
The Ohio State University
If you have any questions or would like to see how the TetraGraph pediatric solution can empower your practice, we’d love to connect!